Response of medulloblastoma cells to vincristine and lomustine

Role of TRKC, CTNNB1 and STK15

Zakia Shinwari, Hindi Al, Essam Al-Shail, Yasser Khafaga, Amani Al-Kofide, Naser Elkum, Abdelilah Aboussekhra

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Vincristine and lomustine are two important chemotherapeutic drugs used for the treatment of different types of neoplasms, including medulloblastomas. Materials and Methods: We investigated the effects of vincristine and lomustine on 12 primary medulloblastoma cell cultures and the DAOY cell line using the annexin V-flow cytometry and immunoblotting techniques, following treatment of cells for different periods of time. Results: Both drugs triggered apoptosis and cell cycle delay at the G2/M phase and also up-regulated p16. Furthermore, the expression of 8 different cancer-related genes were assessed and their mRNA and protein levels were found to be highly heterogeneous and did not correlate in several medulloblastoma cultures. Importantly, there was significant correlation between the level of cadherin-associated protein beta 1 (CTNNB1) and Aurora kinase A (STKI5) proteins and neurotrophic tyrosine kinase receptor type 3 (TRKC) mRNA and the proportion of apoptosis induced by vincristine, the combination of both drugs, and lomustine, respectively. Conclusion: These genes could be of great importance as therapeutic biomarkers during the treatment of medulloblastoma patients with vincristine and lomustine.

Original languageEnglish
Pages (from-to)1721-1733
Number of pages13
JournalAnticancer Research
Volume31
Issue number5
Publication statusPublished - May 2011
Externally publishedYes

Fingerprint

Lomustine
Medulloblastoma
Vincristine
trkC Receptor
Aurora Kinase A
Apoptosis
Messenger RNA
Primary Cell Culture
G2 Phase
Annexin A5
Neoplasm Genes
Receptor Protein-Tyrosine Kinases
Drug Combinations
Cadherins
Therapeutics
Immunoblotting
Pharmaceutical Preparations
Cell Division
Cell Cycle
Flow Cytometry

Keywords

  • Apoptosis
  • Chemotherapy
  • Lomustine
  • Medulloblastoma
  • Vincristine

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Shinwari, Z., Al, H., Al-Shail, E., Khafaga, Y., Al-Kofide, A., Elkum, N., & Aboussekhra, A. (2011). Response of medulloblastoma cells to vincristine and lomustine: Role of TRKC, CTNNB1 and STK15. Anticancer Research, 31(5), 1721-1733.

Response of medulloblastoma cells to vincristine and lomustine : Role of TRKC, CTNNB1 and STK15. / Shinwari, Zakia; Al, Hindi; Al-Shail, Essam; Khafaga, Yasser; Al-Kofide, Amani; Elkum, Naser; Aboussekhra, Abdelilah.

In: Anticancer Research, Vol. 31, No. 5, 05.2011, p. 1721-1733.

Research output: Contribution to journalArticle

Shinwari, Z, Al, H, Al-Shail, E, Khafaga, Y, Al-Kofide, A, Elkum, N & Aboussekhra, A 2011, 'Response of medulloblastoma cells to vincristine and lomustine: Role of TRKC, CTNNB1 and STK15', Anticancer Research, vol. 31, no. 5, pp. 1721-1733.
Shinwari Z, Al H, Al-Shail E, Khafaga Y, Al-Kofide A, Elkum N et al. Response of medulloblastoma cells to vincristine and lomustine: Role of TRKC, CTNNB1 and STK15. Anticancer Research. 2011 May;31(5):1721-1733.
Shinwari, Zakia ; Al, Hindi ; Al-Shail, Essam ; Khafaga, Yasser ; Al-Kofide, Amani ; Elkum, Naser ; Aboussekhra, Abdelilah. / Response of medulloblastoma cells to vincristine and lomustine : Role of TRKC, CTNNB1 and STK15. In: Anticancer Research. 2011 ; Vol. 31, No. 5. pp. 1721-1733.
@article{b7e574ef2d7e412f8081bcede91e1262,
title = "Response of medulloblastoma cells to vincristine and lomustine: Role of TRKC, CTNNB1 and STK15",
abstract = "Background: Vincristine and lomustine are two important chemotherapeutic drugs used for the treatment of different types of neoplasms, including medulloblastomas. Materials and Methods: We investigated the effects of vincristine and lomustine on 12 primary medulloblastoma cell cultures and the DAOY cell line using the annexin V-flow cytometry and immunoblotting techniques, following treatment of cells for different periods of time. Results: Both drugs triggered apoptosis and cell cycle delay at the G2/M phase and also up-regulated p16. Furthermore, the expression of 8 different cancer-related genes were assessed and their mRNA and protein levels were found to be highly heterogeneous and did not correlate in several medulloblastoma cultures. Importantly, there was significant correlation between the level of cadherin-associated protein beta 1 (CTNNB1) and Aurora kinase A (STKI5) proteins and neurotrophic tyrosine kinase receptor type 3 (TRKC) mRNA and the proportion of apoptosis induced by vincristine, the combination of both drugs, and lomustine, respectively. Conclusion: These genes could be of great importance as therapeutic biomarkers during the treatment of medulloblastoma patients with vincristine and lomustine.",
keywords = "Apoptosis, Chemotherapy, Lomustine, Medulloblastoma, Vincristine",
author = "Zakia Shinwari and Hindi Al and Essam Al-Shail and Yasser Khafaga and Amani Al-Kofide and Naser Elkum and Abdelilah Aboussekhra",
year = "2011",
month = "5",
language = "English",
volume = "31",
pages = "1721--1733",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - Response of medulloblastoma cells to vincristine and lomustine

T2 - Role of TRKC, CTNNB1 and STK15

AU - Shinwari, Zakia

AU - Al, Hindi

AU - Al-Shail, Essam

AU - Khafaga, Yasser

AU - Al-Kofide, Amani

AU - Elkum, Naser

AU - Aboussekhra, Abdelilah

PY - 2011/5

Y1 - 2011/5

N2 - Background: Vincristine and lomustine are two important chemotherapeutic drugs used for the treatment of different types of neoplasms, including medulloblastomas. Materials and Methods: We investigated the effects of vincristine and lomustine on 12 primary medulloblastoma cell cultures and the DAOY cell line using the annexin V-flow cytometry and immunoblotting techniques, following treatment of cells for different periods of time. Results: Both drugs triggered apoptosis and cell cycle delay at the G2/M phase and also up-regulated p16. Furthermore, the expression of 8 different cancer-related genes were assessed and their mRNA and protein levels were found to be highly heterogeneous and did not correlate in several medulloblastoma cultures. Importantly, there was significant correlation between the level of cadherin-associated protein beta 1 (CTNNB1) and Aurora kinase A (STKI5) proteins and neurotrophic tyrosine kinase receptor type 3 (TRKC) mRNA and the proportion of apoptosis induced by vincristine, the combination of both drugs, and lomustine, respectively. Conclusion: These genes could be of great importance as therapeutic biomarkers during the treatment of medulloblastoma patients with vincristine and lomustine.

AB - Background: Vincristine and lomustine are two important chemotherapeutic drugs used for the treatment of different types of neoplasms, including medulloblastomas. Materials and Methods: We investigated the effects of vincristine and lomustine on 12 primary medulloblastoma cell cultures and the DAOY cell line using the annexin V-flow cytometry and immunoblotting techniques, following treatment of cells for different periods of time. Results: Both drugs triggered apoptosis and cell cycle delay at the G2/M phase and also up-regulated p16. Furthermore, the expression of 8 different cancer-related genes were assessed and their mRNA and protein levels were found to be highly heterogeneous and did not correlate in several medulloblastoma cultures. Importantly, there was significant correlation between the level of cadherin-associated protein beta 1 (CTNNB1) and Aurora kinase A (STKI5) proteins and neurotrophic tyrosine kinase receptor type 3 (TRKC) mRNA and the proportion of apoptosis induced by vincristine, the combination of both drugs, and lomustine, respectively. Conclusion: These genes could be of great importance as therapeutic biomarkers during the treatment of medulloblastoma patients with vincristine and lomustine.

KW - Apoptosis

KW - Chemotherapy

KW - Lomustine

KW - Medulloblastoma

KW - Vincristine

UR - http://www.scopus.com/inward/record.url?scp=79958123420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958123420&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 1721

EP - 1733

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5

ER -